• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In postmenopausal women with osteoporosis, is zoledronic acid (Reclast) superior in improving T-scores and decreasing fracture rates when compared with placebo?

作者信息

Bilbao Jhun, Pugh Annette, Aspy Cheryl B

出版信息

J Okla State Med Assoc. 2010 Aug;103(8):374-5.

PMID:21049709
Abstract
摘要

相似文献

1
In postmenopausal women with osteoporosis, is zoledronic acid (Reclast) superior in improving T-scores and decreasing fracture rates when compared with placebo?在患有骨质疏松症的绝经后女性中，与安慰剂相比，唑来膦酸（密固达）在改善T值和降低骨折率方面是否更具优势？
J Okla State Med Assoc. 2010 Aug;103(8):374-5.
2
Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.每年静脉注射一次唑来膦酸用于治疗绝经后骨质疏松症。
Ann Pharmacother. 2008 Jul;42(7):1085-9. doi: 10.1345/aph.1K652. Epub 2008 May 27.
3
Reclast approved for osteoporosis treatment in postmenopausal women.
Nurse Pract. 2007 Dec;32(12):12-4. doi: 10.1097/01.NPR.0000300820.36346.a8.
4
Ask the doctor. I've had osteoporosis for several years, and I've been taking alendronate (Fosamax) once a week. I wasn't very good at remembering to take it regularly, so my doctor recently recommended that I start on once-a-year infusions of zoledronic acid (Reclast). Will it work as well to prevent me from breaking a bone?
Harv Womens Health Watch. 2014 Apr;21(8):2.
5
Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.唑来膦酸：新适应症。对绝经后骨质疏松症无治疗优势。
Prescrire Int. 2008 Aug;17(96):143.
6
Ask the doctor. I'm looking for information on Prolia and Reclast as alternatives to Boniva.
Harv Womens Health Watch. 2011 Nov;19(3):8.
7
Zoledronic acid for cancer therapy--induced and postmenopausal bone loss.唑来膦酸用于癌症治疗引起的和绝经后骨质流失。
Expert Opin Pharmacother. 2008 Apr;9(6):1013-28. doi: 10.1517/14656566.9.6.1013.
8
Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.唑来膦酸用于预防接受辅助来曲唑治疗的绝经后早期乳腺癌妇女芳香化酶抑制剂相关骨质流失的综合分析。
Oncologist. 2008 May;13(5):503-14. doi: 10.1634/theoncologist.2007-0206.
9
Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.阿仑膦酸盐和利塞膦酸盐治疗绝经后骨质疏松症的疗效与安全性。
Curr Med Res Opin. 2006 May;22(5):919-28. doi: 10.1185/030079906X100276.
10
Biennial [corrected] IV zoledronic acid (Reclast) for prevention of osteoporosis.
Med Lett Drugs Ther. 2009 Jun 29;51(1315):49.